BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33763482)

  • 1. Upregulation of
    Wang Q; Zheng W
    Biomed Res Int; 2021; 2021():6663367. PubMed ID: 33763482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients.
    Zhuang L; Yang Z; Meng Z
    Biomed Res Int; 2018; 2018():7897346. PubMed ID: 30363964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 4. Identifying
    Liu XT; Liu TT; Wu MY; Chen QX; Zhuang JX; Wang Q
    Genet Test Mol Biomarkers; 2021 Jan; 25(1):68-78. PubMed ID: 33470885
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of key genes and pathways of diagnosis and prognosis in cervical cancer by bioinformatics analysis.
    Yang HJ; Xue JM; Li J; Wan LH; Zhu YX
    Mol Genet Genomic Med; 2020 Jun; 8(6):e1200. PubMed ID: 32181600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer.
    Yang Q; Yu B; Sun J
    Biomed Res Int; 2020; 2020():4625123. PubMed ID: 33282948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
    Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
    J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and transcriptional profiling of the LKB1 tumor suppressor in cervical cancer cells.
    Zhang X; Chen H; Wang X; Zhao W; Chen JJ
    Gynecol Oncol; 2014 Aug; 134(2):372-8. PubMed ID: 24792998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
    Li F; Guo P; Dong K; Guo P; Wang H; Lv X
    J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
    [No Abstract]   [Full Text] [Related]  

  • 10. MiR-200a with CDC7 as a direct target declines cell viability and promotes cell apoptosis in Wilm's tumor via Wnt/β-catenin signaling pathway.
    Liang XL; Wang YL; Wang PR
    Mol Cell Biochem; 2021 Jun; 476(6):2409-2420. PubMed ID: 33599894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of lung adenocarcinoma biomarkers based on bioinformatic analysis and human samples.
    Dong S; Men W; Yang S; Xu S
    Oncol Rep; 2020 May; 43(5):1437-1450. PubMed ID: 32323809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics analysis of the prognostic biomarkers and predictive accuracy of differentially expressed genes in high-risk multiple myeloma based on Gene Expression Omnibus database mining.
    Du C; Guo D; Zhang Y; Gao C; Bai J
    Ann Transl Med; 2022 Dec; 10(24):1325. PubMed ID: 36660705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of crucial aberrantly methylated and differentially expressed genes related to cervical cancer using an integrated bioinformatics analysis.
    Ma X; Liu J; Wang H; Jiang Y; Wan Y; Xia Y; Cheng W
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32368784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-630 inhibits proliferation by targeting CDC7 kinase, but maintains the apoptotic balance by targeting multiple modulators in human lung cancer A549 cells.
    Cao JX; Lu Y; Qi JJ; An GS; Mao ZB; Jia HT; Li SY; Ni JH
    Cell Death Dis; 2014 Sep; 5(9):e1426. PubMed ID: 25255219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer.
    Wu B; Xi S
    BMC Cancer; 2021 Jun; 21(1):733. PubMed ID: 34174849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysis.
    Lei X; Zhang M; Guan B; Chen Q; Dong Z; Wang C
    Hum Genomics; 2021 Jun; 15(1):39. PubMed ID: 34187556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Analysis of Key Genes Driving Gastric Cancer Through Bioinformatics.
    Liu Z; Liu S; Guo J; Sun L; Wang S; Wang Y; Qiu W; Lv J
    Genet Test Mol Biomarkers; 2021 Jan; 25(1):1-11. PubMed ID: 33470887
    [No Abstract]   [Full Text] [Related]  

  • 18. Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target of cervical cancer.
    Wang J; Wang Y; Shen F; Xu Y; Zhang Y; Zou X; Zhou J; Chen Y
    Cancer Med; 2018 Nov; 7(11):5665-5678. PubMed ID: 30334367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five candidate biomarkers associated with the diagnosis and prognosis of cervical cancer.
    Han HY; Mou JT; Jiang WP; Zhai XM; Deng K
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33616161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
    Wu J; Lv Q; Huang H; Zhu M; Meng D
    Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.